Back
Lexaria Bioscience Vs. ESSA Pharma Industry Stock Comparison
Sell
22
LEXX
Lexaria Bioscience
Last Price:
$2.22
Seasonality Move:
77.39%
Sell
24
EPIX
ESSA Pharma
Last Price:
$1.61
Seasonality Move:
35.98%
Sell
22
Lexaria Bioscience (LEXX)
is a Sell
Is Lexaria Bioscience a Buy, Sell or Hold?
-
The current Lexaria Bioscience [LEXX] share price is $2.23. The Score for LEXX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
LEXX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
ESSA Pharma (EPIX)
is a Sell
Is ESSA Pharma a Buy, Sell or Hold?
-
The current ESSA Pharma [EPIX] share price is $1.60. The Score for EPIX is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
EPIX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LEXX Stock Price Chart
What is Lexaria Bioscience's stock price today?
-
The Lexaria Bioscience share price today is $2.23Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LEXX is experiencing buying pressure, which is a positive indicator for future bullish movement.
EPIX Stock Price Chart
What is ESSA Pharma's stock price today?
-
The ESSA Pharma share price today is $1.60Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EPIX is experiencing slight selling pressure.
LEXX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 47.23 | Sell |
Chaikin Money Flow: | 74898 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.07 - 2.41) | Sell |
Bollinger Bands (100): | (2.31 - 3.33) | Sell |
EPIX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.3 | Sell |
Relative Strength Index (14 RSI): | 23.82 | Sell |
Chaikin Money Flow: | -81763 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.64 - 1.78) | Sell |
Bollinger Bands (100): | (2.33 - 6.27) | Sell |
LEXX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.2 | Buy |
20-day SMA: | 2.27 | Sell |
50-day SMA: | 2.38 | Sell |
200-day SMA: | 2.99 | Sell |
8-day EMA: | 2.22 | Buy |
20-day EMA: | 2.26 | Sell |
50-day EMA: | 2.42 | Sell |
200-day EMA: | 2.66 | Sell |
EPIX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.63 | Sell |
20-day SMA: | 1.7 | Sell |
50-day SMA: | 2.92 | Sell |
200-day SMA: | 5.4 | Sell |
8-day EMA: | 1.63 | Sell |
20-day EMA: | 1.8 | Sell |
50-day EMA: | 2.71 | Sell |
200-day EMA: | 4.66 | Sell |
Lexaria Bioscience Earnings Growth & LEXX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.09 per share.
ESSA Pharma Earnings Growth & EPIX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.22 per share.
Lexaria Bioscience Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ESSA Pharma Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |